Beta-blockers and Breast Cancer-Letter
Cancer Epidemiol Biomarkers Prev
.
2021 Sep;30(9):1765.
doi: 10.1158/1055-9965.EPI-21-0527.
Author
Boris Mravec
1
Affiliation
1
Institute of Physiology, Faculty of Medicine, Comenius University in Bratislava, Slovakia Biomedical Research Center, Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovakia. boris.mravec@fmed.uniba.sk.
PMID:
34475119
DOI:
10.1158/1055-9965.EPI-21-0527
No abstract available
Publication types
Letter
Comment
MeSH terms
Adrenergic beta-Antagonists / adverse effects
Angiotensin-Converting Enzyme Inhibitors
Breast Neoplasms* / drug therapy
Female
Humans
Substances
Adrenergic beta-Antagonists
Angiotensin-Converting Enzyme Inhibitors